SPCX enters the week of July 22 with its short base at a new record, its borrow market at an all-time extreme, and a stock that clawed back 3% on Tuesday — but remains down 9% on the week and 33% over the past month.
The lending market has tightened further since last week's already-alarming readings. Availability has dropped to just 7.6% — the lowest level since SPCX began trading, and down from 28.2% when the previous note was published. That means roughly one share remains available for every thirteen already borrowed. The borrow pool is nearly exhausted. Cost to borrow has risen to 2.24%, up about 5% on the week, and the trend has been relentlessly higher since late June's sub-1% readings. What was described a week ago as a constrained market is now, by the data, close to fully shut. The compression that took availability from 628% on June 16 to below 10% in five weeks is without precedent in this stock's short history.
The short base has not retreated — it has grown. Shares short reached 193.5 million by July 21, up 16% on the week and a further step beyond the record set on July 17. The ORTEX short score has edged to 68.6, its highest reading yet, continuing the straight-line ascent from 50.4 on July 9. Critically, availability at 7.6% is itself the 52-week floor — this is not a market where new shorts can easily enter; those adding are doing so at an increasingly steep cost. Options positioning has turned more defensive than at any point in the stock's life. The put/call ratio hit 1.04, close to the 52-week high of 1.06, and runs well above the 20-day mean of 0.93 at roughly 1.7 standard deviations elevated. Bears in the lending market and bears in the options market are aligned.
The analyst picture runs directly counter to all of that. A wave of initiations hit the tape starting July 7, with Deutsche Bank, Cantor Fitzgerald, Macquarie, RBC Capital, Bernstein, Clear Street, and Evercore all opening coverage — almost uniformly bullish, with targets clustered between $217 and $255. Piper Sandler was the outlier, initiating at Neutral with a $156 target on July 16. Needham raised its target from $200 to $250 and held its Buy rating. The consensus mean price target is $240, implying roughly 94% upside from Tuesday's $123.54 close. Macquarie's Paul Golding maintained Outperform with a $250 target as recently as July 21. The valuation tells a similarly bifurcated story: the trailing P/E is an essentially meaningless 210x, the EV/EBITDA is 26x, and the price-to-book is 11.5x — none of these are anchors for a stock being priced on Starship, Starlink, and optionality rather than current earnings power.
Ownership concentration is worth noting. Elon Musk holds 46% of shares, Valor Management holds another 3.8%, and Fidelity's FMR LLC added 28 million shares through June 30 to bring its position to 147 million — a meaningful accumulation. BlackRock added 10.5 million shares in the same period. The retail-facing institutions (Baron Capital, ARK) are present but at sub-1% levels. The concentration of ownership at the top, combined with a short base of 193 million shares, creates structural tension: the float available for lending is functionally exhausted, yet shorts are still finding ways to add.
August 6 is the next scheduled earnings date. The stock has no meaningful prior earnings history to draw on, given how recently it listed. What that print will need to answer — given a 33% drawdown from highs, a record short base, and a consensus target nearly double the current price — is whether the revenue and margin trajectory justifies any of the targets the Street established in the past two weeks, or whether the bears who built this position at record cost and record tightness were earlier to the fundamental story.
See the live data behind this article on ORTEX.
Open SPCX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
